From Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter:

Scribe_Tx_leaders
Scribe_Tx_leaders

Scribe Therapetics co-founder and vice president of platform Brett Staahl (left) and co-founder and CEO Benjamin Oakes (right). Photo by Scribe Therapeutics.